Epigral Limited — Others, 28-01-2025: Copy of Newspaper Publication

Epigral has announced a board meeting to discuss the financial results for the quarter and nine months ended 31st December 2024. The company has published these unaudited results in the Financial Express, a step that underscores its commitment to transparency. This update may enhance investor confidence by showcasing financial performance, with an opportunity for scrutiny of operational effectiveness. As the company transitions from its previous identity as Meghmani Finechem, maintaining clear communication on financial health could positively influence market sentiment, reflecting a proactive governance approach.